Cite
Hepatitis B-related outcomes following direct-acting antiviral therapy in Taiwanese patients with chronic HBV/HCV co-infection.
MLA
Yeh, Ming-Lun, et al. “Hepatitis B-Related Outcomes Following Direct-Acting Antiviral Therapy in Taiwanese Patients with Chronic HBV/HCV Co-Infection.” Journal of Hepatology, vol. 73, no. 1, July 2020, pp. 62–71. EBSCOhost, https://doi.org/10.1016/j.jhep.2020.01.027.
APA
Yeh, M.-L., Huang, C.-F., Huang, C.-I., Holmes, J. A., Hsieh, M.-H., Tsai, Y.-S., Liang, P.-C., Tsai, P.-C., Hsieh, M.-Y., Lin, Z.-Y., Chen, S.-C., Huang, J.-F., Dai, C.-Y., Chuang, W.-L., Chung, R. T., & Yu, M.-L. (2020). Hepatitis B-related outcomes following direct-acting antiviral therapy in Taiwanese patients with chronic HBV/HCV co-infection. Journal of Hepatology, 73(1), 62–71. https://doi.org/10.1016/j.jhep.2020.01.027
Chicago
Yeh, Ming-Lun, Chung-Feng Huang, Ching-I. Huang, Jacinta A. Holmes, Meng-Hsuan Hsieh, Yi-Shan Tsai, Po-Cheng Liang, et al. 2020. “Hepatitis B-Related Outcomes Following Direct-Acting Antiviral Therapy in Taiwanese Patients with Chronic HBV/HCV Co-Infection.” Journal of Hepatology 73 (1): 62–71. doi:10.1016/j.jhep.2020.01.027.